Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Feb;60(2):337–344. doi: 10.1128/iai.60.2.337-344.1992

Secretory immune responses to Mycoplasma pulmonis.

M J Steffen 1, J L Ebersole 1
PMCID: PMC257633  PMID: 1730465

Abstract

Formalinized Mycoplasma pulmonis, along with aluminum hydroxide as an adjuvant, was used to subcutaneously immunize rats in the vicinity of the salivary gland to examine the characteristics of the secretory immune response to this pathogen. The induction of specific antibody to this microorganism was detected in serum and the exocrine fluids, namely, saliva and lung lavage fluid. Both immunoglobulin G (IgG) and IgA isotype antibodies were detected in each of these fluids after primary and secondary local immunizations. Serum responses from immunized animals were significantly greater than in the control group, but a dose response was not observed in either IgG or IgA antibody at the dosages selected for immunization. Salivary IgG antibody responses peaked early after both the primary and secondary immunizations, exhibiting a clear dose response. Salivary IgA in immunized groups was significantly greater than that in the control group but displayed little dose-dependent kinetics, and, at the termination of the experiment, this response had not yet peaked. Lung lavage IgG and IgA were minimal after the primary immunization when the antibody was normalized to total protein but displayed dose-dependent kinetics after a secondary challenge. IgG peaked immediately after a secondary challenge, while IgA peak responses were observed only after 20 days. A positive correlation was noted between the serum, saliva, and lung lavage fluid IgGs after both primary and secondary immunizations and only after a secondary challenge for IgA. In this study we were able to elicit a secretory immune response, consisting of both IgG and IgA, which exhibited a dose-dependent characteristic in lung lavage fluid to this immunogen. Additionally, a positive correlation of antibody levels between saliva and lung lavage fluid suggests that saliva could be used as an indicator for monitoring specific antibody to M. pulmonis in lung lavage secretions without requiring invasive, deleterious procedures.

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergmann K. C., Waldman R. H. Enhanced murine respiratory tract IgA antibody response to oral influenza vaccine when combined with a lipoidal amine (avridine). Int Arch Allergy Appl Immunol. 1988;87(3):334–335. doi: 10.1159/000234695. [DOI] [PubMed] [Google Scholar]
  2. Brandtzaeg P. Two types of IgA immunocytes in man. Nat New Biol. 1973 May 30;243(126):142–143. doi: 10.1038/newbio243142a0. [DOI] [PubMed] [Google Scholar]
  3. Brunner H., Greenberg H. B., James W. D., Horswood R. L., Couch R. B., Chanock R. M. Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun. 1973 Oct;8(4):612–620. doi: 10.1128/iai.8.4.612-620.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cassell G. H., Davis J. K., Lindsey J. R. Control of Mycoplasma pulmonis infection in rats and mice: detection and elimination vs. vaccination. Isr J Med Sci. 1981 Jul;17(7):674–677. [PubMed] [Google Scholar]
  5. Cassell G. H., Lindsey J. R., Baker H. J. Immune response of pathogen-free mice inoculated intranasally with Mycoplasma pulmonis. J Immunol. 1974 Jan;112(1):124–136. [PubMed] [Google Scholar]
  6. Clancy R. L., Cripps A. W., Husband A. J., Buckley D. Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine. Infect Immun. 1983 Feb;39(2):491–496. doi: 10.1128/iai.39.2.491-496.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colwell D. E., Michalek S. M., McGhee J. R. Lps gene regulation of mucosal immunity and susceptibility to Salmonella infection in mice. Curr Top Microbiol Immunol. 1986;124:121–147. doi: 10.1007/978-3-642-70986-9_8. [DOI] [PubMed] [Google Scholar]
  8. Cox D. S., Taubman M. A. Systemic priming of the secretory antibody response with soluble and particulate antigens and carriers. J Immunol. 1982 Apr;128(4):1844–1848. [PubMed] [Google Scholar]
  9. Cui Z. D., Tristram D., LaScolea L. J., Kwiatkowski T., Jr, Kopti S., Ogra P. L. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun. 1991 Apr;59(4):1465–1469. doi: 10.1128/iai.59.4.1465-1469.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davidson M. K., Lindsey J. R., Parker R. F., Tully J. G., Cassell G. H. Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect Immun. 1988 Aug;56(8):2156–2162. doi: 10.1128/iai.56.8.2156-2162.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Davis J. K., Cassell G. H. Murine respiratory mycoplasmosis in LEW and F344 rats: strain differences in lesion severity. Vet Pathol. 1982 May;19(3):280–293. doi: 10.1177/030098588201900306. [DOI] [PubMed] [Google Scholar]
  12. Davis J. K., Thorp R. B., Maddox P. A., Brown M. B., Cassell G. H. Murine respiratory mycoplasmosis in F344 and LEW rats: evolution of lesions and lung lymphoid cell populations. Infect Immun. 1982 May;36(2):720–729. doi: 10.1128/iai.36.2.720-729.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Davis J. K., Thorp R. B., Parker R. F., White H., Dziedzic D., D'Arcy J., Cassell G. H. Development of an aerosol model of murine respiratory mycoplasmosis in mice. Infect Immun. 1986 Oct;54(1):194–201. doi: 10.1128/iai.54.1.194-201.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ebersole J. L., Frey D. E., Taubman M. A., Smith D. J. An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans. J Periodontal Res. 1980 Nov;15(6):621–632. doi: 10.1111/j.1600-0765.1980.tb00321.x. [DOI] [PubMed] [Google Scholar]
  15. Ebersole J. L., Steffen M. J. Aging effects on secretory IgA immune responses. Immunol Invest. 1989 Jan-May;18(1-4):59–68. doi: 10.3109/08820138909112227. [DOI] [PubMed] [Google Scholar]
  16. Ebersole J. L., Taubman M. A., Smith D. J., Frey D. E. Carrier-specific recognition for induction of secretory IgA anamnestic antibody responses. Immunology. 1987 Oct;62(2):185–191. [PMC free article] [PubMed] [Google Scholar]
  17. Ford C. W., Hamel J. C., Stapert D., Yancey R. J. Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. J Med Microbiol. 1989 Apr;28(4):259–266. doi: 10.1099/00222615-28-4-259. [DOI] [PubMed] [Google Scholar]
  18. Gregory R. L., Filler S. J. Protective secretory immunoglobulin A antibodies in humans following oral immunization with Streptococcus mutans. Infect Immun. 1987 Oct;55(10):2409–2415. doi: 10.1128/iai.55.10.2409-2415.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lai W. C., Bennett M., Lu Y. S., Pakes S. P. Vaccination of Lewis rats with temperature-sensitive mutants of Mycoplasma pulmonis: adoptive transfer of immunity by spleen cells but not by sera. Infect Immun. 1991 Jan;59(1):346–350. doi: 10.1128/iai.59.1.346-350.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lindsey J. R., Baker H. J., Overcash R. G., Cassell G. H., Hunt C. E. Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol. 1971 Sep;64(3):675–708. [PMC free article] [PubMed] [Google Scholar]
  21. Mestecky J., McGhee J. R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987;40:153–245. doi: 10.1016/s0065-2776(08)60240-0. [DOI] [PubMed] [Google Scholar]
  22. Ogra P. L. Mucosal immune response to poliovirus vaccines in childhood. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S361–S368. doi: 10.1093/clinids/6.supplement_2.s361. [DOI] [PubMed] [Google Scholar]
  23. Onderdonk A. B., Kasper D. L., Cisneros R. L., Bartlett J. G. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977 Jul;136(1):82–89. doi: 10.1093/infdis/136.1.82. [DOI] [PubMed] [Google Scholar]
  24. Poirier T. P., Kehoe M. A., Beachey E. H. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med. 1988 Jul 1;168(1):25–32. doi: 10.1084/jem.168.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Saito H., Watanabe T., Horikawa Y. Effects of Lactobacillus casei on Pseudomonas aeruginosa infection in normal and dexamethasone-treated mice. Microbiol Immunol. 1986;30(3):249–259. doi: 10.1111/j.1348-0421.1986.tb00940.x. [DOI] [PubMed] [Google Scholar]
  26. Sato H., Ito A., Chiba J., Sato Y. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect Immun. 1984 Nov;46(2):422–428. doi: 10.1128/iai.46.2.422-428.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Simecka J. W., Davis J. K., Cassell G. H. Serum antibody does not account for differences in the severity of chronic respiratory disease caused by Mycoplasma pulmonis in LEW and F344 rats. Infect Immun. 1989 Nov;57(11):3570–3575. doi: 10.1128/iai.57.11.3570-3575.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Smith D. J., Taubman M. A., Ebersole J. L. Effects of local immunization with glucosyltransferase on colonization of hamsters by Streptococcus mutans. Infect Immun. 1982 Aug;37(2):656–661. doi: 10.1128/iai.37.2.656-661.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith D. J., Taubman M. A., Ebersole J. L. Local and systemic antibody response to oral administration of glucosyltransferase antigen complex. Infect Immun. 1980 May;28(2):441–450. doi: 10.1128/iai.28.2.441-450.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Smith D. J., Taubman M. A. Oral immunization of humans with Streptococcus sobrinus glucosyltransferase. Infect Immun. 1987 Nov;55(11):2562–2569. doi: 10.1128/iai.55.11.2562-2569.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Svennerholm A. M., Hanson L. A., Holmgren J., Lindblad B. S., Nilsson B., Quereshi F. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect Immun. 1980 Nov;30(2):427–430. doi: 10.1128/iai.30.2.427-430.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Taylor G., Howard C. J., Gourlay R. N. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice. Infect Immun. 1977 May;16(2):422–431. doi: 10.1128/iai.16.2.422-431.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Winner L., 3rd, Mack J., Weltzin R., Mekalanos J. J., Kraehenbuhl J. P., Neutra M. R. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun. 1991 Mar;59(3):977–982. doi: 10.1128/iai.59.3.977-982.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES